In low income countries, for parents, for patients, cancer is a sentence. An anticipated long way to painful and distressing death, because treatment and care are lacking. Unless we take action now to make a difference, the existing health care infrastructure in low income countries will be overwhelmed by the predicted increase in cancer incidence.[...]
We dream about a website that could explain our Metronomics Global Health Initiative, what it can bring to people suffering from cancer and connect people who share our vision....the birth of our project.
With this website, we want to prove that we are a team of people who can develop innovative state-of-the-art projects promoting alternative global[...]
Children treated with metronomic chemotherapy in a low-income country: METROMALI-01. Fousseyni T, Diawara M, Pasquier E, André N. J Pediatr Hematol Oncol. 2011 Jan;33(1):31-4.
Abstract BACKGROUND: Metronomic chemotherapy (MC) is defined as the frequent administration of chemotherapy at doses below the maximal tolerated dose and with no prolonged[...]
A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing solid Tumours. (SFCE METRO 01)
Sponsor: Assistance Publique Hopitaux De Marseille
Purpose To establish the anti-tumour effect of this[...]
link to AP-HM here
Présentation de l´institution Etablissement public de santé, regroupant 4 hôpitaux et près de 3 500 lits et places, l’AP-HM est le 1er centre hospitalier de la région PACA .Soins, enseignement, recherche, telles sont les trois missions que le l’Assistance -Publique-Hôpitaux de Marseille réalise quotidiennement. C’est aussi un pôle[...]